Jump to content

Study panning anti-malaria drug Trump took against COVID faces new questions


Recommended Posts

Posted

Study panning anti-malaria drug Trump took against COVID faces new questions

By Michael Erman

 

2020-06-02T213036Z_1_LYNXMPEG5124V_RTROPTP_3_HEALTH-CORONAVIRUS-HYDROXYCHLOROQUINE.JPG

FILE PHOTO: The drug hydroxychloroquine, pushed by U.S. President Donald Trump and others in recent months as a possible treatment to people infected with the coronavirus disease (COVID-19), is displayed at the Rock Canyon Pharmacy in Provo, Utah, U.S. May 27, 2020. REUTERS/George Frey/File Photo

 

NEW YORK (Reuters) - British medical journal the Lancet on Tuesday said it had concerns about data behind an influential article that found hydroxychloroquine increased the risk of death in COVID-19 patients, a conclusion that undercut scientific interest in the medicine championed by U.S. President Donald Trump.

 

Hydroxychloroquine - which has anti-inflammatory and antiviral properties - inhibited the coronavirus in laboratory experiments but has not been proven effective in humans, particularly in placebo-controlled, randomized clinical trials considered the gold standard for data.

 

The debate has become highly politicized, and many scientists have voiced concern.

 

Nearly 150 doctors signed an open letter to the Lancet last week calling the article's conclusions into question and asking to make public the peer review comments that preceded publication.

 

"This is not some sideshow or minor issue," said Dr. Walid Gellad, a professor at University of Pittsburgh's medical school, who was not a signatory of the letter but has been critical of the study.

 

"We're in an unprecedented pandemic. We've organized these enormous clinical trials to figure out if something works. And this study stopped or paused a couple of those trials, and changed the narrative around a drug that no one knows if it works or not," he said.

 

The observational study published in the Lancet on May 22 looked at 96,000 hospitalized COVID-19 patients, some treated with the decades-old malaria drug that Trump said he took and has urged others to use.

 

Several clinical trials were put on hold after the study was published.

 

The study, using data provided by healthcare data analytics firm Surgisphere, was not a traditional clinical trial that would have compared hydroxychloroquine to a placebo or other medicine.

 

The Lancet's editors said in a note that serious scientific questions about the study were brought to their attention and an independent audit of the data has already been commissioned.

 

Surgisphere said in a statement that the audit "will bring further transparency to our work (and) further highlight the quality of our work."

 

Earlier on Tuesday, the New England Journal of Medicine (NEJM) said it was concerned about the quality of the data behind a different study it published in May that also used data from Surgisphere and had the same lead author.

 

Dr. Mandeep Mehra, the lead author and a professor of Medicine at Harvard Medical School, defended the use of the Surgisphere dataset as an intermediary step until clinical data is available.

 

"I eagerly await word from the independent audits, the results of which will inform any further action," Mehra said in a statement after the Lancet note.

 

The World Health Organization (WHO) suspended hydroxychloroquine's use in a large trial on COVID-19 patients after the Lancet study. Following the WHO trial suspension, the governments of France, Italy and Belgium halted the use of hydroxychloroquine for COVID-19 patients.

 

Among the critics of the study to sign the letter last week were several academics from the University of Oxford and Mahidol Oxford Tropical Medicine Research Unit (MORU) in Bangkok, which had been conducting the global "COPCOV" trial of hydroxychloroquine as a treatment of COVID-19.

 

The trial was paused last week, after the Lancet article.

 

In March, Trump, with little scientific evidence, said hydroxychloroquine used in combination with the antibiotic azithromycin had "a real chance to be one of the biggest game changers in the history of medicine." He later said he took the drugs preventively after two people who worked at the White House were diagnosed with COVID-19.

 

Trump and Brazilian President Jair Bolsonaro discussed a joint research effort on using hydroxychloroquine as both a prophylaxis and treatment for the coronavirus, the White House said on Tuesday.

 

(Reporting by Michael Erman; additional reporting by Alistair Smout, Editing by Bill Berkrot, Peter Henderson and Tom Brown)

 

reuters_logo.jpg

-- © Copyright Reuters 2020-06-03
 
  • Haha 2
Posted
8 hours ago, webfact said:

particularly in placebo-controlled, randomized clinical trials considered the gold standard for data.

how many people here know that vaccine placebo's are not salt water, but another TOXIC vaccine full of chemicals, same as they will use a meningitis vaccine as placebo for the corona vaccine trials...

 

placebo should mean:  sugar pill or salt water (saline) with chemicals...

 

hydroxychloroquine should be used with ZINC to prevent (so not when the patient is on a ventilator on his way to DEATH) to prevent the virus from penetrating new cells...

 

 

 

 

  • Like 1
  • Confused 1
  • Sad 1
  • Thanks 1
Posted

I quite agree with the scientists who asked to see the data. That's a good way to check the scientific value of the study.

As stated in the OP, before this study, no one knew whether this drug was working or not, so this study needs to be carefully reviewed. It would also make sense to go on with other trials for the time being.

That's a sound scientific debate. Nothing to do with the ridiculous touting of this drug by Trump and Trumpers.

  • Like 1
  • Haha 1
Posted
9 hours ago, OneMoreFarang said:

Another reason why Trump should be removed and investigated. Follow the money. Who profited from his constant recommendation of a dangerous drug.

 

I see you think your politically biased opinion outweighs the 150 doctors and the venerable Lancet!

  • Like 1
Posted
21 minutes ago, candide said:

I quite agree with the scientists who asked to see the data. That's a good way to check the scientific value of the study.

As stated in the OP, before this study, no one knew whether this drug was working or not, so this study needs to be carefully reviewed. It would also make sense to go on with other trials for the time being.

That's a sound scientific debate. Nothing to do with the ridiculous touting of this drug by Trump and Trumpers.

 

Totally agree. And for balance, nothing to do with the ridiculous exaggerations of the dangers of this drug by those who are more interested in attacking Trump.

  • Sad 1
  • Thanks 1
Posted
9 hours ago, TopDeadSenter said:

No. You believe the mainstream media narrative that the drug is useless, without proper scientific tests, because it is a convenient weapon to bash Donald Trump. 

No i believe doctors and specialists.

 

Btw, if it may help, and cant hurt, why did trump stop taking it?

 

Riddle me that.

  • Like 2
  • Confused 1
Posted
16 minutes ago, Baerboxer said:

 

Totally agree. And for balance, nothing to do with the ridiculous exaggerations of the dangers of this drug by those who are more interested in attacking Trump.

So why did trump stop taking it.

  • Like 1
  • Confused 1
Posted
4 minutes ago, OneMoreFarang said:

Ok, maybe I should have written: It has possible bad side-effects.

I read one study of that drug was cancelled because too many participants had too many bad side effects.

We had to sign waivers saying we knew the side effects and were given the pills. Usually for malaria they would give 1 week (daily) before entering area and 30 days after leaving the area. 

  • Like 2
Posted
1 hour ago, Baerboxer said:

 

Totally agree. And for balance, nothing to do with the ridiculous exaggerations of the dangers of this drug by those who are more interested in attacking Trump.

Who started politicizing this issue? As you know, in most developped countries,  governments and political parties are not touting any controversial drug. It remains a debate between health professionals.

  • Like 1
  • Haha 1

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
  • Recently Browsing   0 members

    • No registered users viewing this page.




×
×
  • Create New...